With more than 70 million diabetic patients, India is known as the diabetes capital of the world. On top of that, the country is on its way to reach 200 million pre-diabetics as well. Driven by the increasing number of diabetes patients in the cou...
Aurobindo Pharma Ltd on said it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility at Pydibhimavaram in Andhra Pradesh. The company's Unit XI at Pydibhimavaram is an API...
Biotheus Inc., a clinical-stage biotech company focused on the discovery and development of biologics for oncology and inflammatory diseases, announced that they have entered into a collaboration agreement with Hansoh Pharmaceuticals, for Biotheus'..
Biocon said on Tuesday that its Biocon Biologics subsidiary has secured all the regulatory approvals for the acquisition of Viatris' biosimilar business and is in the process of completing an $800 million equity infusion as part of the deal...
SK Biopharmaceuticals, a global innovative pharmaceutical company, announced that the state-run Korea Drug Development Fund (KDDF) has decided to support and finance the company's development of SKL27969, which is being evaluated as potential...
HitGen Inc. announced that it has entered into a research collaboration agreement with Daewoong Pharmaceutical Co., Ltd (“Daewoongâ€), a global healthcare group in the Republic of Korea, dedicated to improving the quality of patients' lives. HitGen...
Fujifilm India Pvt Ltd, a pioneer in diagnostic imaging and information systems for healthcare facilities has expanded its pulmonology solutions portfolio by launching a new slim video bronchoscope called EB-710P, which was unveiled at the National..
Alembic Pharmaceuticals Limited announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide capsules, 25 mg and 50 mg...
AstraZeneca’s Imfinzi (durvalumab) in combination with Imjudo (tremelimumab) plus platinum-based chemotherapy has been approved in the US for the treatment of adult patients with Stage IV (metastatic) non-small cell lung cancer (NSCLC)...
Companies are now partnering with an expert turnkey provider can streamline their development processes without the burden of costs associated with in-house manufacturing. In this article, let's look into the key trends in pharma turnkey projects.
, CDSCO.jpg)
